Q&A: How pharma partnerships could benefit digital therapeutics companies
At the tail end of 2022, Click Therapeutics announced it was expanding its partnership with Boehringer Ingelheim focused on developing prescription digital therapeutics for patients with schizophrenia. Pharma partnerships aren’t new for digital health players, or for Click, which has several products in its development pipeline. The company’s chief strategy officer, Austin Speier, said Click looks […]